DE60133036D1 - Oral einnehmbare zubereitung von mistellectinen und verfahren - Google Patents

Oral einnehmbare zubereitung von mistellectinen und verfahren

Info

Publication number
DE60133036D1
DE60133036D1 DE60133036T DE60133036T DE60133036D1 DE 60133036 D1 DE60133036 D1 DE 60133036D1 DE 60133036 T DE60133036 T DE 60133036T DE 60133036 T DE60133036 T DE 60133036T DE 60133036 D1 DE60133036 D1 DE 60133036D1
Authority
DE
Germany
Prior art keywords
preparation
mistellectines
mistletoe
acceptable preparation
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133036T
Other languages
English (en)
Other versions
DE60133036T2 (de
Inventor
Ian Pryme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60133036D1 publication Critical patent/DE60133036D1/de
Publication of DE60133036T2 publication Critical patent/DE60133036T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60133036T 2000-11-14 2001-11-12 Oral einnehmbare zubereitung von mistellectinen und verfahren Expired - Lifetime DE60133036T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24795700P 2000-11-14 2000-11-14
US247957P 2000-11-14
PCT/NO2001/000446 WO2002040041A2 (en) 2000-11-14 2001-11-12 Orally ingestible preparation of mistletoe lectins and method

Publications (2)

Publication Number Publication Date
DE60133036D1 true DE60133036D1 (de) 2008-04-10
DE60133036T2 DE60133036T2 (de) 2009-04-02

Family

ID=22937047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133036T Expired - Lifetime DE60133036T2 (de) 2000-11-14 2001-11-12 Oral einnehmbare zubereitung von mistellectinen und verfahren

Country Status (13)

Country Link
US (1) US7550159B2 (de)
EP (1) EP1341811B9 (de)
JP (1) JP2004513926A (de)
KR (1) KR100832614B1 (de)
AT (1) ATE387209T1 (de)
AU (1) AU2120502A (de)
CY (1) CY1107965T1 (de)
DE (1) DE60133036T2 (de)
DK (1) DK1341811T3 (de)
ES (1) ES2301576T3 (de)
NZ (1) NZ526202A (de)
PT (1) PT1341811E (de)
WO (1) WO2002040041A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418800B1 (de) 2001-07-09 2007-05-09 University of Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
KR101191081B1 (ko) 2008-05-19 2012-10-15 김종배 운동수행능력 증강 및 피로억제 효과를 갖는 겨우살이추출물
RU2644332C1 (ru) * 2016-12-30 2018-02-08 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ получения растительного лектина ml1 из омелы белой и фармацевтическая композиция на его основе (варианты).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229876A1 (de) * 1992-09-04 1994-03-10 Uwe Dr Pfueller Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen
DE4242902A1 (de) * 1992-12-18 1994-06-23 Madaus Ag Verfahren zur Herstellung von Lektinkonzentraten aus Mistelextrakten und daraus hergestellte standardisierte Präparate zur Erhöhung der natürlichen Immunresistenz und für die Verwendung in der Tumor-Therapie
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
DE4421895A1 (de) * 1994-06-23 1996-01-04 Private Uni Witten Herdecke Gm Verfahren zur Isolierung von Isolektinen aus der Mistel
WO1996032122A1 (en) * 1995-04-14 1996-10-17 University Of Southern California Mistletoe extract and method
DE59503524D1 (de) * 1995-06-26 1998-10-15 Madaus Ag Koeln Rekombinantes Mistellektin (rML)
WO1997011967A1 (de) * 1995-09-27 1997-04-03 Thomas David Extrakt von viscum album (weisse mistel)
CA2389080C (en) * 1999-10-26 2012-02-21 Chiron Corporation Mistletoe lectins as mucosal adjuvants

Also Published As

Publication number Publication date
CY1107965T1 (el) 2013-09-04
US20040052869A1 (en) 2004-03-18
EP1341811B1 (de) 2008-02-27
KR100832614B1 (ko) 2008-05-27
ES2301576T3 (es) 2008-07-01
NZ526202A (en) 2005-08-26
PT1341811E (pt) 2008-06-04
DE60133036T2 (de) 2009-04-02
WO2002040041A3 (en) 2002-07-25
EP1341811A2 (de) 2003-09-10
US7550159B2 (en) 2009-06-23
DK1341811T3 (da) 2008-06-30
JP2004513926A (ja) 2004-05-13
KR20030066664A (ko) 2003-08-09
AU2120502A (en) 2002-05-27
EP1341811B9 (de) 2008-11-05
WO2002040041A2 (en) 2002-05-23
ATE387209T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
DE60323090D1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
DE60222264D1 (en) Phenylpyrazolderivate als seh-inhibitoren
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
HUP0302874A2 (hu) Eljárás risperidon előállítására
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
CY1113894T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη
CY1107965T1 (el) Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
DE60224257D1 (de) Retinolderivate und verfahren zu deren herstellung
HUP0301479A2 (hu) Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására
DE60233936D1 (de) Therapeutische Zusammenseztungen zur Toleranzinduktion
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
DE69630761D1 (de) Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
ATE360431T1 (de) Saururus chinensis-extrakt zur prophylaxis und behandlung neurodegenerativer krankheiten
ZA200300675B (en) Pharmaceutical preparation of the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma.
WO2002026258A3 (en) Treatment of immune-mediated diseases by oral administration of plasma fractions
DE60233819D1 (de) Doppelester

Legal Events

Date Code Title Description
8364 No opposition during term of opposition